AK

Anupam Kumari

Active Director Director DIN 08806423
DIN 08806423 First appointment Jul 2020 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2020
Shareholding value •••• Premium profile

About Anupam Kumari

Data last updated:

Anupam Kumari is a Director at Biolone Biotech Private Limited (since 2020). The company operates in Trading. Biolone Biotech Private Limited reported revenue of ₹82,985 (FY 2021).

DIN 08806423
Primary Designation Director
Industry Trading
First Appointment 23 Jul 2020
Oldest Company Age 6 yrs
Largest company Biolone Biotech Private Limited · ₹82,985 (FY 2021)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Biolone Biotech Private Limited U51909BR2020PTC047047
Director23 Jul 20202020₹82,985 (FY 2021)Active

Board colleagues of Anupam Kumari

NameDINCompanyDesignation
Kumar Shambhu08806412Biolone Biotech Private LimitedDirector

Directorship timeline

Open interactive timeline →
Biolone Biotech Private Limited
Premium access

Shareholding and investment profile for Anupam Kumari

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Anupam Kumari

Anupam Kumari currently holds 1 directorship: Biolone Biotech Private Limited (Director, since 23 Jul 2020, revenue ₹82,985 (FY 2021)).

Anupam Kumari was first appointed on 23 Jul 2020 as Director at Biolone Biotech Private Limited.

The current boards of Anupam Kumari's companies include Kumar Shambhu (Biolone Biotech Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available